A Multicenter, Phase IV, Interventional Study to Assess the Efficacy and Safety of TARGIN(R) (Oxycodone/Naloxone) in Korean Patients With Spinal Disorders
Latest Information Update: 24 May 2016
At a glance
- Drugs Oxycodone/naloxone (Primary)
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- Acronyms TALENT
- Sponsors Mundipharma International
- 06 Apr 2016 Status changed from recruiting to completed.
- 21 Mar 2013 New trial record